カテゴリー： Market Monitor Global, 世界, 医療/バイオ

筋強直性ジストロフィー1型（DM1）の世界市場見通し2023年-2029年

◆英語タイトル：Myotonic Dystrophy Type 1 (DM1) Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23JU5791）◆商品コード：MMG23JU5791
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年6月
◆ページ数：76
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
◆産業分野：医薬品＆医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Myotonic Dystrophy Type 1 (DM1) Market 調査レポートは次の情報を含め、グローバルにおけるの筋強直性ジストロフィー1型（DM1）市場規模と予測を収録しています。・世界の筋強直性ジストロフィー1型（DM1）市場：売上、2018年-2023年、2024年-2029年
・世界の筋強直性ジストロフィー1型（DM1）市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の筋強直性ジストロフィー1型（DM1）市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「Exondys」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

筋強直性ジストロフィー1型（DM1）のグローバル主要企業は、Dyne、 Audentes、 Pfizer、 Vertex、 PepGen、 NeuBase Therapeutics、 Lupin、 AMO Pharma、 Expansion Therapeutics、 Harmony Biosciencesなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、筋強直性ジストロフィー1型（DM1）のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界の筋強直性ジストロフィー1型（DM1）市場：タイプ別、2018年-2023年、2024年-2029年
世界の筋強直性ジストロフィー1型（DM1）市場：タイプ別市場シェア、2022年
・Exondys、Emflaza、Translarna

世界の筋強直性ジストロフィー1型（DM1）市場：用途別、2018年-2023年、2024年-2029年
世界の筋強直性ジストロフィー1型（DM1）市場：用途別市場シェア、2022年
・病院、診療所、在宅医療

世界の筋強直性ジストロフィー1型（DM1）市場：地域・国別、2018年-2023年、2024年-2029年
世界の筋強直性ジストロフィー1型（DM1）市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業における筋強直性ジストロフィー1型（DM1）のグローバル売上、2018年-2023年
・主要企業における筋強直性ジストロフィー1型（DM1）のグローバル売上シェア、2022年
・主要企業における筋強直性ジストロフィー1型（DM1）のグローバル販売量、2018年-2023年
・主要企業における筋強直性ジストロフィー1型（DM1）のグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Dyne、 Audentes、 Pfizer、 Vertex、 PepGen、 NeuBase Therapeutics、 Lupin、 AMO Pharma、 Expansion Therapeutics、 Harmony Biosciences

*************************************************************

・調査・分析レポートの概要
筋強直性ジストロフィー1型（DM1）市場の定義
市場セグメント
世界の筋強直性ジストロフィー1型（DM1）市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の筋強直性ジストロフィー1型（DM1）市場規模
世界の筋強直性ジストロフィー1型（DM1）市場規模：2022年 VS 2029年
世界の筋強直性ジストロフィー1型（DM1）市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの筋強直性ジストロフィー1型（DM1）の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の筋強直性ジストロフィー1型（DM1）製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：Exondys、Emflaza、Translarna
筋強直性ジストロフィー1型（DM1）のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、診療所、在宅医療
筋強直性ジストロフィー1型（DM1）の用途別グローバル売上・予測

・地域別市場分析
地域別筋強直性ジストロフィー1型（DM1）市場規模 2022年と2029年
地域別筋強直性ジストロフィー1型（DM1）売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Dyne、 Audentes、 Pfizer、 Vertex、 PepGen、 NeuBase Therapeutics、 Lupin、 AMO Pharma、 Expansion Therapeutics、 Harmony Biosciences
...

This report aims to provide a comprehensive presentation of the global market for Myotonic Dystrophy Type 1 (DM1), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Myotonic Dystrophy Type 1 (DM1). This report contains market size and forecasts of Myotonic Dystrophy Type 1 (DM1) in global, including the following market information:
Global Myotonic Dystrophy Type 1 (DM1) Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Myotonic Dystrophy Type 1 (DM1) Market Sales, 2018-2023, 2024-2029, (Units)
Global top five Myotonic Dystrophy Type 1 (DM1) companies in 2022 (%)
The global Myotonic Dystrophy Type 1 (DM1) market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Exondys Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Myotonic Dystrophy Type 1 (DM1) include Dyne, Audentes, Pfizer, Vertex, PepGen, NeuBase Therapeutics, Lupin, AMO Pharma and Expansion Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myotonic Dystrophy Type 1 (DM1) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Myotonic Dystrophy Type 1 (DM1) Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, by Type, 2022 (%)
Exondys
Emflaza
Translarna
Global Myotonic Dystrophy Type 1 (DM1) Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Home Care
Global Myotonic Dystrophy Type 1 (DM1) Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (Units)
Global Myotonic Dystrophy Type 1 (DM1) Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Myotonic Dystrophy Type 1 (DM1) revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Myotonic Dystrophy Type 1 (DM1) revenues share in global market, 2022 (%)
Key companies Myotonic Dystrophy Type 1 (DM1) sales in global market, 2018-2023 (Estimated), (Units)
Key companies Myotonic Dystrophy Type 1 (DM1) sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Dyne
Audentes
Pfizer
Vertex
PepGen
NeuBase Therapeutics
Lupin
AMO Pharma
Expansion Therapeutics
Harmony Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Myotonic Dystrophy Type 1 (DM1), market overview.
Chapter 2: Global Myotonic Dystrophy Type 1 (DM1) market size in revenue and volume.
Chapter 3: Detailed analysis of Myotonic Dystrophy Type 1 (DM1) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Myotonic Dystrophy Type 1 (DM1) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Myotonic Dystrophy Type 1 (DM1) capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Myotonic Dystrophy Type 1 (DM1) Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Myotonic Dystrophy Type 1 (DM1) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Myotonic Dystrophy Type 1 (DM1) Overall Market Size
2.1 Global Myotonic Dystrophy Type 1 (DM1) Market Size: 2022 VS 2029
2.2 Global Myotonic Dystrophy Type 1 (DM1) Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Myotonic Dystrophy Type 1 (DM1) Sales: 2018-2029
3 Company Landscape
3.1 Top Myotonic Dystrophy Type 1 (DM1) Players in Global Market
3.2 Top Global Myotonic Dystrophy Type 1 (DM1) Companies Ranked by Revenue
3.3 Global Myotonic Dystrophy Type 1 (DM1) Revenue by Companies
3.4 Global Myotonic Dystrophy Type 1 (DM1) Sales by Companies
3.5 Global Myotonic Dystrophy Type 1 (DM1) Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Myotonic Dystrophy Type 1 (DM1) Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
3.8 Tier 1, Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Players in Global Market
3.8.1 List of Global Tier 1 Myotonic Dystrophy Type 1 (DM1) Companies
3.8.2 List of Global Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Myotonic Dystrophy Type 1 (DM1) Market Size Markets, 2022 & 2029
4.1.2 Exondys
4.1.3 Emflaza
4.1.4 Translarna
4.2 By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
4.2.1 By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2023
4.2.2 By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2024-2029
4.2.3 By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
4.3 By Type – Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
4.3.1 By Type – Global Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2023
4.3.2 By Type – Global Myotonic Dystrophy Type 1 (DM1) Sales, 2024-2029
4.3.3 By Type – Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
4.4 By Type – Global Myotonic Dystrophy Type 1 (DM1) Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Myotonic Dystrophy Type 1 (DM1) Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Home Care
5.2 By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
5.2.1 By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2023
5.2.2 By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2024-2029
5.2.3 By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
5.3 By Application – Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
5.3.1 By Application – Global Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2023
5.3.2 By Application – Global Myotonic Dystrophy Type 1 (DM1) Sales, 2024-2029
5.3.3 By Application – Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
5.4 By Application – Global Myotonic Dystrophy Type 1 (DM1) Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Myotonic Dystrophy Type 1 (DM1) Market Size, 2022 & 2029
6.2 By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue & Forecasts
6.2.1 By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2023
6.2.2 By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2024-2029
6.2.3 By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
6.3 By Region – Global Myotonic Dystrophy Type 1 (DM1) Sales & Forecasts
6.3.1 By Region – Global Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2023
6.3.2 By Region – Global Myotonic Dystrophy Type 1 (DM1) Sales, 2024-2029
6.3.3 By Region – Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2029
6.4.2 By Country – North America Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2029
6.4.3 US Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.4.4 Canada Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.4.5 Mexico Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2029
6.5.2 By Country – Europe Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2029
6.5.3 Germany Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5.4 France Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5.5 U.K. Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5.6 Italy Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5.7 Russia Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5.8 Nordic Countries Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.5.9 Benelux Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2029
6.6.2 By Region – Asia Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2029
6.6.3 China Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.6.4 Japan Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.6.5 South Korea Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.6.6 Southeast Asia Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.6.7 India Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2029
6.7.2 By Country – South America Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2029
6.7.3 Brazil Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.7.4 Argentina Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, 2018-2029
6.8.3 Turkey Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.8.4 Israel Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.8.5 Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
6.8.6 UAE Myotonic Dystrophy Type 1 (DM1) Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Dyne
7.1.1 Dyne Company Summary
7.1.2 Dyne Business Overview
7.1.3 Dyne Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.1.4 Dyne Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.1.5 Dyne Key News & Latest Developments
7.2 Audentes
7.2.1 Audentes Company Summary
7.2.2 Audentes Business Overview
7.2.3 Audentes Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.2.4 Audentes Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.2.5 Audentes Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.3.4 Pfizer Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Vertex
7.4.1 Vertex Company Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.4.4 Vertex Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.4.5 Vertex Key News & Latest Developments
7.5 PepGen
7.5.1 PepGen Company Summary
7.5.2 PepGen Business Overview
7.5.3 PepGen Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.5.4 PepGen Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.5.5 PepGen Key News & Latest Developments
7.6 NeuBase Therapeutics
7.6.1 NeuBase Therapeutics Company Summary
7.6.2 NeuBase Therapeutics Business Overview
7.6.3 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.6.4 NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.6.5 NeuBase Therapeutics Key News & Latest Developments
7.7 Lupin
7.7.1 Lupin Company Summary
7.7.2 Lupin Business Overview
7.7.3 Lupin Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.7.4 Lupin Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.7.5 Lupin Key News & Latest Developments
7.8 AMO Pharma
7.8.1 AMO Pharma Company Summary
7.8.2 AMO Pharma Business Overview
7.8.3 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.8.4 AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.8.5 AMO Pharma Key News & Latest Developments
7.9 Expansion Therapeutics
7.9.1 Expansion Therapeutics Company Summary
7.9.2 Expansion Therapeutics Business Overview
7.9.3 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.9.4 Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.9.5 Expansion Therapeutics Key News & Latest Developments
7.10 Harmony Biosciences
7.10.1 Harmony Biosciences Company Summary
7.10.2 Harmony Biosciences Business Overview
7.10.3 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Major Product Offerings
7.10.4 Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales and Revenue in Global (2018-2023)
7.10.5 Harmony Biosciences Key News & Latest Developments
8 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity, Analysis
8.1 Global Myotonic Dystrophy Type 1 (DM1) Production Capacity, 2018-2029
8.2 Myotonic Dystrophy Type 1 (DM1) Production Capacity of Key Manufacturers in Global Market
8.3 Global Myotonic Dystrophy Type 1 (DM1) Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Myotonic Dystrophy Type 1 (DM1) Supply Chain Analysis
10.1 Myotonic Dystrophy Type 1 (DM1) Industry Value Chain
10.2 Myotonic Dystrophy Type 1 (DM1) Upstream Market
10.3 Myotonic Dystrophy Type 1 (DM1) Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Myotonic Dystrophy Type 1 (DM1) Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Myotonic Dystrophy Type 1 (DM1) in Global Market
Table 2. Top Myotonic Dystrophy Type 1 (DM1) Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Myotonic Dystrophy Type 1 (DM1) Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Myotonic Dystrophy Type 1 (DM1) Revenue Share by Companies, 2018-2023
Table 5. Global Myotonic Dystrophy Type 1 (DM1) Sales by Companies, (Units), 2018-2023
Table 6. Global Myotonic Dystrophy Type 1 (DM1) Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Myotonic Dystrophy Type 1 (DM1) Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Myotonic Dystrophy Type 1 (DM1) Product Type
Table 9. List of Global Tier 1 Myotonic Dystrophy Type 1 (DM1) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myotonic Dystrophy Type 1 (DM1) Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2018-2023
Table 15. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2024-2029
Table 16. By Application – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2018-2023
Table 20. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2024-2029
Table 21. By Region – Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2018-2023
Table 25. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales (Units), 2024-2029
Table 26. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2018-2023
Table 29. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2024-2029
Table 30. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2018-2023
Table 33. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2024-2029
Table 34. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2018-2023
Table 37. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2024-2029
Table 38. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2018-2023
Table 41. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2024-2029
Table 42. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2018-2023
Table 45. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales, (Units), 2024-2029
Table 46. Dyne Company Summary
Table 47. Dyne Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 48. Dyne Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Dyne Key News & Latest Developments
Table 50. Audentes Company Summary
Table 51. Audentes Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 52. Audentes Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Audentes Key News & Latest Developments
Table 54. Pfizer Company Summary
Table 55. Pfizer Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 56. Pfizer Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Pfizer Key News & Latest Developments
Table 58. Vertex Company Summary
Table 59. Vertex Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 60. Vertex Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Vertex Key News & Latest Developments
Table 62. PepGen Company Summary
Table 63. PepGen Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 64. PepGen Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. PepGen Key News & Latest Developments
Table 66. NeuBase Therapeutics Company Summary
Table 67. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 68. NeuBase Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. NeuBase Therapeutics Key News & Latest Developments
Table 70. Lupin Company Summary
Table 71. Lupin Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 72. Lupin Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Lupin Key News & Latest Developments
Table 74. AMO Pharma Company Summary
Table 75. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 76. AMO Pharma Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. AMO Pharma Key News & Latest Developments
Table 78. Expansion Therapeutics Company Summary
Table 79. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 80. Expansion Therapeutics Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Expansion Therapeutics Key News & Latest Developments
Table 82. Harmony Biosciences Company Summary
Table 83. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Product Offerings
Table 84. Harmony Biosciences Myotonic Dystrophy Type 1 (DM1) Sales (Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Harmony Biosciences Key News & Latest Developments
Table 86. Myotonic Dystrophy Type 1 (DM1) Production Capacity (Units) of Key Manufacturers in Global Market, 2021-2023 (Units)
Table 87. Global Myotonic Dystrophy Type 1 (DM1) Capacity Market Share of Key Manufacturers, 2021-2023
Table 88. Global Myotonic Dystrophy Type 1 (DM1) Production by Region, 2018-2023 (Units)
Table 89. Global Myotonic Dystrophy Type 1 (DM1) Production by Region, 2024-2029 (Units)
Table 90. Myotonic Dystrophy Type 1 (DM1) Market Opportunities & Trends in Global Market
Table 91. Myotonic Dystrophy Type 1 (DM1) Market Drivers in Global Market
Table 92. Myotonic Dystrophy Type 1 (DM1) Market Restraints in Global Market
Table 93. Myotonic Dystrophy Type 1 (DM1) Raw Materials
Table 94. Myotonic Dystrophy Type 1 (DM1) Raw Materials Suppliers in Global Market
Table 95. Typical Myotonic Dystrophy Type 1 (DM1) Downstream
Table 96. Myotonic Dystrophy Type 1 (DM1) Downstream Clients in Global Market
Table 97. Myotonic Dystrophy Type 1 (DM1) Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Myotonic Dystrophy Type 1 (DM1) Segment by Type in 2022
Figure 2. Myotonic Dystrophy Type 1 (DM1) Segment by Application in 2022
Figure 3. Global Myotonic Dystrophy Type 1 (DM1) Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Myotonic Dystrophy Type 1 (DM1) Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Myotonic Dystrophy Type 1 (DM1) Revenue, 2018-2029 (US$, Mn)
Figure 7. Myotonic Dystrophy Type 1 (DM1) Sales in Global Market: 2018-2029 (Units)
Figure 8. The Top 3 and 5 Players Market Share by Myotonic Dystrophy Type 1 (DM1) Revenue in 2022
Figure 9. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 11. By Type - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 12. By Type - Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 15. By Application - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 16. By Application - Global Myotonic Dystrophy Type 1 (DM1) Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 20. By Region - Global Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 21. By Country - North America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 22. By Country - North America Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 23. US Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 28. Germany Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 29. France Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 37. China Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 41. India Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 43. By Country - South America Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 44. Brazil Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Myotonic Dystrophy Type 1 (DM1) Sales Market Share, 2018-2029
Figure 48. Turkey Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Myotonic Dystrophy Type 1 (DM1) Revenue, (US$, Mn), 2018-2029
Figure 52. Global Myotonic Dystrophy Type 1 (DM1) Production Capacity (Units), 2018-2029
Figure 53. The Percentage of Production Myotonic Dystrophy Type 1 (DM1) by Region, 2022 VS 2029
Figure 54. Myotonic Dystrophy Type 1 (DM1) Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 筋強直性ジストロフィー1型（DM1）の世界市場見通し2023年-2029年(Myotonic Dystrophy Type 1 (DM1) Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 筋強直性ジストロフィー治療薬の世界市場見通し2023年-2029年
  • 眼咽頭型筋ジストロフィー（OPMD）の世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆